Fig. 2: Blood transcriptional discrimination of participants with and without replicative infection by time from SARS-CoV-2 challenge. | Nature Communications

Fig. 2: Blood transcriptional discrimination of participants with and without replicative infection by time from SARS-CoV-2 challenge.

From: SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections

Fig. 2

A Point estimates for area under the receiver operating characteristic curve (AUROC) stratified by blood transcriptional signature and time after virus challenge. B Individual (data points) and loess smoothed summary (line ±95% CI) for standardised blood transcript levels of MX1 and IFI27 in sequential time points after challenge, for participants with (N = 17) and without (N = 16) replicative viral infection.

Back to article page